These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7). Nilsson C; Eriksson E Eur J Pharmacol; 1992 Aug; 218(2-3):205-11. PubMed ID: 1358634 [TBL] [Abstract][Full Text] [Related]
9. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms. Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227 [TBL] [Abstract][Full Text] [Related]
10. D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording. Einhorn LC; Gregerson KA; Oxford GS J Neurosci; 1991 Dec; 11(12):3727-37. PubMed ID: 1683898 [TBL] [Abstract][Full Text] [Related]
11. Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation. Novi F; Millan MJ; Corsini GU; Maggio R J Neurochem; 2007 Aug; 102(4):1410-24. PubMed ID: 17532788 [TBL] [Abstract][Full Text] [Related]
12. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats. Rendt J; Oxford GS Endocrinology; 1994 Aug; 135(2):501-8. PubMed ID: 8033799 [TBL] [Abstract][Full Text] [Related]
13. Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Urban JD; Vargas GA; von Zastrow M; Mailman RB Neuropsychopharmacology; 2007 Jan; 32(1):67-77. PubMed ID: 16554739 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors. Knoerzer TA; Watts VJ; Nichols DE; Mailman RB J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869 [TBL] [Abstract][Full Text] [Related]
15. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist. Smith HP; Nichols DE; Mailman RB; Lawler CP Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873 [TBL] [Abstract][Full Text] [Related]
16. The novel antidyskinetic drug sarizotan elicits different functional responses at human D2-like dopamine receptors. Kuzhikandathil EV; Bartoszyk GD Neuropharmacology; 2006 Sep; 51(4):873-84. PubMed ID: 16844149 [TBL] [Abstract][Full Text] [Related]
17. Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine. Gleason SD; Witkin JM Psychopharmacology (Berl); 2006 May; 186(1):25-31. PubMed ID: 16575553 [TBL] [Abstract][Full Text] [Related]
18. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release. Aihara K; Shimada J; Miwa T; Tottori K; Burris KD; Yocca FD; Horie M; Kikuchi T Brain Res; 2004 Apr; 1003(1-2):9-17. PubMed ID: 15019558 [TBL] [Abstract][Full Text] [Related]
19. The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat. Schechter MD Psychopharmacology (Berl); 1995 May; 119(1):79-84. PubMed ID: 7675953 [TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling. Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]